This review concluded that the bronchoalveolar lavage galactomannan assay was an accurate test for diagnosing proven and probable invasive aspergillosis and was more powerful than serum galactomannan. Some relevant studies may have been missed. The conclusions regarding bronchoalveolar lavage seem appropriate, although the number of patients was small, especially within the subgroup analyses. The authors did not evaluate serum galactomannan.
Authors' objectives
To determine the overall accuracy of bronchoalveolar lavage galactomannan assay in the diagnosis of invasive aspergillosis.
Searching
MEDLINE and EMBASE were searched for articles published in full in English up to January 2010; search terms were reported. Reference lists of included studies and related publications were searched. Abstracts and meeting proceedings were excluded.
Study selection
Studies that evaluated the accuracy of the galactomannan assay Platelia for diagnosis of invasive aspergillosis in immunocompromised patients using bronchoalveolar lavage were included if they used the original or revised European Organization for Research and Treatment of Cancer/Mycoses as the reference standard. Studies had to include at least 10 patients and provide sufficient data to construct 2x2 tables of test performance.
Most of the studies recruited adults with haematologic malignancy. More than half of the studies used a modified version of the reference standard criteria (modifications varied across studies). Most of the studies administered an antifungal intervention. Most studies required a single bronchoalveolar lavage sample to establish a positive diagnosis. More than half of the studies used a cut-off index value for a positive test of 1 and other studies used 0.5, 1.5 or 2.
Two independent reviewers selected studies for the review; disagreements were resolved by discussion with a third reviewer.
Assessment of study quality
It appeared that two independent reviewers assessed study quality using the adapted 11-point QUADAS tool and the STARD reporting statement. Authors were contacted where there was insufficient information to score a criterion.
Data extraction
Two independent reviewers extracted data to construct 2x2 tables of test performance. Authors were contacted for additional information where required. Sensitivity and specificity were calculated along with 95% confidence intervals (CI). Disagreements were resolved by discussion with a third reviewer
Methods of synthesis
Pooled estimates of sensitivity and specificity were calculated using the bivariate random-effects model. Summary receiver operating characteristic (SROC) curves were presented. Positive and negative likelihood ratios with 95% CI were calculated from the pooled estimates of sensitivity and specificity. In the primary analyses, results of the reference standard were categorised into proven or probable invasive aspergillosis (positive result) and possible or no invasive aspergillosis (negative result). Classification as proven (positive result) or probable/possible/no invasive aspergillosis (negative result) was also investigated. Where different thresholds for a positive test were reported within a study, the one that offered the best diagnostic performance was included in the meta-analysis. Heterogeneity was assessed using the Ι² statistic. Heterogeneity was investigated in terms of population, study design, direction of data collection, patient recruitment method, reference standard criteria, blinding, presence of incorporation bias, number of positive samples
